Opinion: Target the Vector

Officials’ increased emphasis on mosquito control could benefit public health efforts beyond the ongoing Zika outbreak.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Aedes aegypti eggsWIKIMEDIA, CDCThe fast spread of Zika, which is now impacting nearly 50 countries on three continents, in combination with our limited understanding of the virus and infection-related symptoms and how the ongoing outbreak in Brazil might affect the upcoming Olympic Games in Rio, has garnered significant attention for this emerging pathogen. However, this recent attention on the Zika virus could wane quickly, particularly after the completion of the Olympic Games—which will justifiably not be cancelled or postponed due to the outbreak—and as a result of more positive news on the diagnostics and vaccine development fronts. Therefore, the public’s concerns regarding the Zika virus—including the corresponding pressure on politicians to provide reasonable funding to fight its spread—should be utilized to develop broader and more encompassing strategies to combat mosquito-borne diseases in general.

Although the Zika virus can have severe consequences for the affected individuals, the global impact of the Zika virus pales in comparison to that of other mosquito-borne diseases. With more than half a million deaths each year, mosquito-borne diseases such as malaria, dengue, and yellow fever still represent one of the 10 most common causes of morbidity and mortality in low-income countries, highlighting the need for a broad strategy incorporating the variety of mosquito-borne diseases as well as regional and local circumstances.

In particular, the focus on a Zika vaccine—although important—could result in a misplaced illusion of protection, thereby removing the required attention and future financial backing to combat mosquito-borne diseases.

The economic framework for the development, production, storage, and application of vaccines targeting mosquito-borne ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Mirco Junker

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo